Roundtable Discussion: Overcoming Barriers to Move IBD Biomarkers into Validated Diagnostics that Impact Patient Care & Future Therapies
- Define the role of diagnostics in IBD to accelerate precision medicine adoption
- Stepwise development from discovery to clinical validation and commercialization
- Address regulatory and commercial hurdles so validated tests can reach patients, not just publications